EFTA01019439.pdf
👁 1
💬 0
📄 Extracted Text (535 words)
From: J <[email protected]>
To: Bryan Bishop
Subject: Re: more gene editing (updates)
Date: Wed, 17 Oct 2018 10:33:43 +0000
i dont think you have enogh info to decide whether these partners are good or bad
On Tue, Oct 16, 2018 at 11:26 PM Bryan Bishop < wrote:
Legality -- we can do R&D in the US but yes I will need to do careful analysis about medical tourism and
other options. Ultimately maybe do partnerships with overseas clinics and get commissions on referring the
customers. We can just sell the additive DNA to those overseas clinics. Many ways to structure. In the US,
self-experimentation is not explicitly banned. US animal testing is open.
During my Tokyo trip the investor that made me an offer is part of a financial services company. They operate
various exchanges in Tokyo, and acquired a bitcoin exchange. So I have to really decide are they the right
partners and/or maybe I shouldn't care.
Concerned about future of Allen Brain Institute and others.
On Tue, Oct 16, 2018 at 5:41 AM J <jeevacation®gmail.com> wrote:
we need to get a read on legal. first. cant do anything where US rules apply to us citizens regardless of
where.? its such a great subject. what type of investors.
On Tue, Oct 16, 2018 at 12:57 AM Bryan Bishop < > wrote:
Last week, Japan announced that they are allowing human embryo gene editing (
https:f/www.nature.com/articles/d41586-018-06847-7) in the lab.
By tremendous fortune, I happened to be in Tokyo last week speaking with a handful of investors. I got a
bite (and now the question is, do I want to take /their/ money....).
Attached is an updated diligence doc of technical references. Did you want a second set of eyes to look at
this?
One of the new references in the attachment ("Generation of human oogonia...") is a recent development
regarding in vitro gametogenesis, i.e. producing sperm/egg cells from other tissues. Eventually this will
mean we can make practically unlimited modifications to the cells before generating an embryo. This isn't
a requirement for our initial work but ifs a very important direction that will unlock more commercial
opportunities.
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
EFTA01019439
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA01019440
ℹ️ Document Details
SHA-256
c215e47a5d3a495b3adfb940ac90475d024b1c2544de08dd96c01073c0171e39
Bates Number
EFTA01019439
Dataset
DataSet-9
Type
document
Pages
2
💬 Comments 0